The loss of GoHealth under GAAP for 9 months of 2020 amounted to $230.299 million, an increase of 2.4 times compared to $68.769 million in the previous year. Revenue increased 72% to $431.427 million against $250.8 million a year earlier. Results for 9 months of 2019 are calculated by combining figures before and after the acquisition of 100% of Norvax, which took place on September 13, 2019.
The loss of GoHealth under GAAP for 9 months of 2020 amounted to $230.299 million, an increase of 2.4 times compared to $68.769 million in the previous year. Revenue increased 72% to $431.427 million against $250.8 million a year earlier. Results for 9 months of 2019 are calculated by combining figures before and after the acquisition of 100% of Norvax, which took place on September 13, 2019. 
investors.gohealth.com
English (US) 